Prelude Capital Management’s Enfusion, Inc. ENFN Stock Holding History

Prelude Capital Management’s Portfolio ENFN Stock Details ENFN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-255,622	Closed	-$2.85M	–	1460
2025 Q1	$2.85M	Buy	+255,622	New	+$2.83M	0.22%	93

Other funds holding ENFN

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Prelude Capital Management's ENFN Position: Q2 2025 in Review

Prelude Capital Management sold out of Enfusion, Inc. (ENFN) in Q2 2025, closing a stake of 255,622 shares — an estimated $2.85M sold.

Prelude Capital Management first reported a position in ENFN in Q1 2025 and held it in 1 quarter. The position peaked at $2.85M in Q1 2025. 2 funds tracked by Wall St. Rank hold ENFN as of Q2 2025.

Prelude Capital Management reported no remaining Enfusion, Inc. position as of Q2 2025 after selling out during the quarter.
Prelude Capital Management sold 255,622 Enfusion, Inc. shares in Q2 2025, an estimated $2.85M.
Prelude Capital Management first reported a position in Enfusion, Inc. in Q1 2025 and held it in 1 quarter.
Prelude Capital Management's Enfusion, Inc. position peaked at $2.85M in Q1 2025.
2 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q2 2025.

Based on Prelude Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.